Arsenic Trioxide With or Without Ascorbic Acid in Treating Patients With Myelofibrosis

NCT01014546 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

5

Enrollment

OTHER

Sponsor class

Stopped low accrual

Conditions

Essential Thrombocythemia
Polycythemia Vera
Primary Myelofibrosis

Interventions

DRUG: Arsenic Trioxide
DIETARY_SUPPLEMENT: Ascorbic Acid
OTHER: Laboratory Biomarker Analysis
OTHER: Pharmacological Study

Sponsor

Roswell Park Cancer Institute

Collaborators

[object Object]